Congressional Briefings
The Partnership For Safe Medicines Congressional Briefings, September 24, 2019
On September 24, 2019, the Partnership for Safe Medicines and 19 partner organizations held two congressional briefings about the real dangers counterfeit drugs pose to Americans. In all, the briefing offered a clear picture of why importation cannot solve the problem of high drug prices in the U.S. Canada does not have enough prescription drugs to share with U.S.patients, and organized crime is poised to expand the counterfeit drug trade into the U.S. to bridge the gap without regard for the health and safety of U.S. residents: “The money to be made is far too great to worry about human life.”
Learn more about the event and read briefing materials here.
Past Briefings
- Partnership For Safe Medicines January 2019 Congressional Briefings (January 31, 2019)
- The Partnership for Safe Medicines Congressional Briefing (April 10, 2018)
- The Partnership For Safe Medicines Congressional Briefing (March 16 and 17, 2017)
- "Current Threats to American Patients from Counterfeiters," PSM Counterfeit Drug Congressional Briefing (March 7 and 8, 2016)
- "Moving Beyond the Avastin Incident," PSM Counterfeit Drug Congressional Briefing held on March 15 (March 09, 2012)
- Dr. Bryan Liang Speaking at a Congressional Briefing (March 01, 2012)
- Congressional Briefing: The Human Impact of Counterfeit Drugs (September 13, 2011)
- Fake Online Pharmacies US Congressional Briefing (June 23, 2011)
- Prescription Drug Safety Hill Briefing (March 30, 2011)